Skip to content Skip to footer
AFCR 的「快速支付系統」(「轉數快」) 號碼是 113719686。捐款人現可通過網上或手機銀行輸入此號碼（而不需要AFCR 的完整銀行賬號）來進行捐款。

全球峰會及頒獎典禮

首頁全球峰會及頒獎典禮

全球峰會及頒獎典禮

2024年峰會日期：2024年10月18日，星期五

联合主办

亞洲癌症研究基金會、美國國家癌症研究基金會和AIM-HI加速基金會將聯合舉辦一場內容豐富的活動，慶祝癌症研究的發現以及腫瘤學創新的影響。特色項目包括癌症研究的新前沿、婦女領導獎頒獎典禮和Szent-Györgyi獎頒獎典禮。活動將在美國華盛頓特區現場舉行，並為無法親臨現場的人提供線上直播。參加者將包括癌症研究的捐贈者、癌症患者、學術界和行業專業人士，以及其他對了解癌症研究發現和強大的抗疾病產品和工具感興趣的公眾成員。我們希望您能加入我們！

為什麼您應該參加這次活動？

  • 受世界知名演講者的啟發，了解轉化性癌症研究的最新格局變化
  • 積极參與與關鍵意見領袖的引人思考的討論
  • 與屢獲殊榮的先鋒科學家進行親自互動，並加入對他們突破性癌症發現的慶祝
2023 年活動議程

Part I: New Frontiers for Cancer Research

8:30 pm – 12:30 am

8:30 pm – 8:40 pm:
Opening and Welcome Remarks:
Sujuan Ba, Ph.D., President & CEO of NFCR, Co-Founder of AIM-HI & Founder of AFCR
Webster K. Cavenee, Ph.D., Chair of NFCR Scientific Advisory Board; Distinguished Professor Emeritus, University of California, San Diego
8:40 pm – 9:10 pm:
Keynote Speech:

James P. Allison, Ph.D., Professor & Chair of Immunology, Executive Director of Immunotherapy Platform, The University of Texas MD Anderson Cancer Center

SESSION I: NEW APPROACHES TO CANCER TREATMENTS
9:10 pm – 10:30 pm:

Moderator: Suzanne Topalian, M.D., Professor of Oncology and Surgery, Johns Hopkins University

Panel Members:

  • Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard
  • Avery D. Posey, Ph.D., Assistant Professor, University of Pennsylvania Perelman School of Medicine
  • Azra Raza, M.D., Chan Soon-Shiong Professor of Medicine, Columbia University in New York
  • Thea D. Tlsty, Ph.D., Professor of Pathology, University of California San Francisco
10:30 PM -10:45 PM COFFEE BREAK
SESSION II: PANEL DISCUSSION ON PRECISION MEDICINE
10:45 pm – 11:35 pm:
Moderator: Brian Leyland-Jones, MBBS, Ph.D., Chief Medical Officer & Board Director, NFCR
Panel Members:
  • Massimo Cristofanilli, M.D., Chief, Breast Medical Oncology, Weil Cornell Medicine
  • Raju Kucherlapati, Ph.D., Paul C. Cabot Professor of Genetics, Harvard Medical School
  • Min Li, Ph.D., Professor of Medicine, Surgery and Cell Biology, The University of Oklahoma
  • Drew Pardoll, M.D., Ph.D., Abeloff Professor of Oncology, Medicine, Pathology and Molecular Biology and Genetics, Johns Hopkins Medicine
  • W. K. Alfred Yung, M.D., Professor of Neuro-oncology, University of Texas MD Anderson Cancer Center
SESSION III: SZENT-GYÖRGYI PRIZE PANEL ON STATUS OF CANCER BIOLOGY
11:35 pm – 12:30 am:
Moderator: Douglas R. Lowy, M.D., Principal Deputy Director, National Cancer Institute
Panel Members:
  • Webster K. Cavenee, Ph.D., Distinguished Professor Emeritus, University of California, San Diego
  • Carlo M. Croce, M.D., John W. Wolfe Chair in Human Cancer Genetics, The Ohio State University
  • Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School
  • Steven A. Rosenberg, M.D., Ph.D., Chief, Surgery Branch, National Cancer Institute
  • Peter K. Vogt, Ph.D., Professor Emeritus of Molecular Medicine, Scripps Research

Part II: Luncheon Award Ceremony and Forum for Women’s Leadership & Entrepreneurship

1:00 am – 2:15 am

BEACON AWARD CEREMONY
1:00 am – 1:40 am:

Emcee: Rose Wang, MBA, Board Director of AIM-HI; Founder & CEO of 1104 Health

Welcome Remarks & Introduction of the 2023 Beacon Award Recipient:

Sujuan Ba, Ph.D., President & CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2023 Beacon Award Selection Committee

Presenting the Beacon Award Medallion to the Recipient by the Award Selection Committee Members

2023 Beacon Award Winner Award Speech:

Monica M. Bertagnolli, M.D., Director, National Cancer Institute

2023 WOMEN'S VENTURE COMPETITION AWARD CEREMONY
1:40 am – 2:15 am:

Pamela Garzone, Ph.D., Co-Chair of the Competition Selection & Judging Committees; Chief Development Officer of Anixa Biosciences

Dimitra Georganopoulou, Ph.D.,Co-Chair of the Competition Investment Committee; General Partner of Qral Ventures

  • First Prize:Sarah Hein, Ph.D., Co-Founder & CEO of March Biosciences
  • Second Prize: Lily Zou, Ph.D., MBA, CEO & Co-Founder of Degron Therapeutics
2:15 AM - 2:30 AM COFFEE BREAK

Part III: Emerging Oncology Companies Showcase

2:30 am – 3:30 am

PRESENTATIONS BY EMERGING ONCOLOGY COMPANIES
2:30 am – 3:20 am:
Moderator: Matt Tremblay, Ph.D., Chair of the Board, AIM-HI; CEO of Blackbird Laboratories
  • Ignacio Asial, Ph.D., Founder & CEO of DotBio
  • Stacy Blain, Ph.D., Co-Founder, CSO & Acting CEO of Concarlo Therapeutics
  • Jeremiah Johnson, Ph.D., Co-Founder, Chair – Scientific Advisory Board, & Director of Window Therapeutics
  • John Luk, DMedSc, EMBA, CEO of Arbele Bio
  • Andrea van Elsas, Ph.D., CSO of ManaT Bio
3:20 am – 3:30 am:
Q&A
3:20 am – 3:30 am:

Closing Remarks:

Matt Tremblay, Ph.D., Chair of the Board, AIM-HI; CEO of Blackbird Laboratories

INTERMISSION

Part IV: 2023 Szent-Györgyi Prize Cocktail & Dinner Award Ceremony

7:00 am – 9:00 am Szent-Györgyi Prize Dinner & Award Ceremony
PRESENTATIONS BY EMERGING ONCOLOGY COMPANIES
7:00 am – 9:00 am:

Szent-Györgyi Prize Dinner Award Ceremony

Moment of Silence

Opening and Welcome Remarks:

Sujuan Ba, Ph.D., President & CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR; Co-Chair of the 2023 Selection Committee for the Szent-Györgyi Prize

Keynote Speech:

Helmut Sies, M.D., Professor Emeritus, Department of Biochemistry and Molecular Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Introduction of the 2023 Szent-Györgyi Prize Winner:

Rakesh K. Jain, Ph.D., 2022 Szent-Györgyi Prize Winner & Chair of the 2023 Selection Committee for the Szent-Györgyi Prize; Andrew Werk Cook Professor of Radiation Oncology, Harvard Medical School; Director, Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital

Award Trophy Presentation:

Sujuan Ba, Ph.D., Co-Chair of the 2023 Selection Committee for the Szent-Györgyi Prize

2023 Szent-Györgyi Prize Winner Award Speech:

Isaac P. Witz, Ph.D., Professor Emeritus at Tel Aviv University; Head of the Laboratory of Tumor Microenvironment & Metastasis Research at The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences

Acknowledgments & Closing Remarks:

Alfred Slanetz, Ph.D., Chair of the Board, NFCR; CEO of Geneius Biotechnology

贊助機會

有關活動贊助的查詢可通過電子郵件發送至contact@afcr.org。